400 related articles for article (PubMed ID: 16397142)
1. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.
Xu J; Kimball TR; Lorenz JN; Brown DA; Bauskin AR; Klevitsky R; Hewett TE; Breit SN; Molkentin JD
Circ Res; 2006 Feb; 98(3):342-50. PubMed ID: 16397142
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse.
Noorali S; Kurita T; Woolcock B; de Algara TR; Lo M; Paralkar V; Hoodless P; Vielkind J
Differentiation; 2007 Apr; 75(4):325-36. PubMed ID: 17286605
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.
Kempf T; Eden M; Strelau J; Naguib M; Willenbockel C; Tongers J; Heineke J; Kotlarz D; Xu J; Molkentin JD; Niessen HW; Drexler H; Wollert KC
Circ Res; 2006 Feb; 98(3):351-60. PubMed ID: 16397141
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice.
Yang HY; Cheng CF; Djoko B; Lian WS; Tu CF; Tsai MT; Chen YH; Chen CC; Cheng CJ; Yang RB
Cardiovasc Res; 2007 Jul; 75(1):139-47. PubMed ID: 17442284
[TBL] [Abstract][Full Text] [Related]
6. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
7. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
8. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation.
Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A
Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746
[TBL] [Abstract][Full Text] [Related]
9. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth.
Abd El-Aziz SH; Endo Y; Miyamaori H; Takino T; Sato H
Cancer Sci; 2007 Sep; 98(9):1330-5. PubMed ID: 17640303
[TBL] [Abstract][Full Text] [Related]
11. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy.
Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S
Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.
Zimmers TA; Jin X; Hsiao EC; McGrath SA; Esquela AF; Koniaris LG
Shock; 2005 Jun; 23(6):543-8. PubMed ID: 15897808
[TBL] [Abstract][Full Text] [Related]
18. Lmcd1/Dyxin, a novel Z-disc associated LIM protein, mediates cardiac hypertrophy in vitro and in vivo.
Frank D; Frauen R; Hanselmann C; Kuhn C; Will R; Gantenberg J; Füzesi L; Katus HA; Frey N
J Mol Cell Cardiol; 2010 Oct; 49(4):673-82. PubMed ID: 20600098
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
Oka T; Maillet M; Watt AJ; Schwartz RJ; Aronow BJ; Duncan SA; Molkentin JD
Circ Res; 2006 Mar; 98(6):837-45. PubMed ID: 16514068
[TBL] [Abstract][Full Text] [Related]
20. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
Liu X; Sun SQ; Hassid A; Ostrom RS
Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
